US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

ABBV

AbbVie (ABBV)

AbbVie Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

1 2 3 4 5 6 7 8 9 10 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
08/05/2024	16:00	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NYSE:ABBV	AbbVie Inc
08/05/2024	07:00	PR Newswire (Canada)	QULIPTA(MC) (atogépant) est maintenant approuvé par Santé Canada pour la prévention de la migraine chronique chez les adultes	NYSE:ABBV	AbbVie Inc
08/05/2024	07:00	PR Newswire (Canada)	QULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults	NYSE:ABBV	AbbVie Inc
07/05/2024	19:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ABBV	AbbVie Inc
06/05/2024	07:00	PR Newswire (US)	AbbVie to Present at the Bank of America Securities Healthcare Conference	NYSE:ABBV	AbbVie Inc
26/04/2024	06:47	IH Market News	U.S. Futures Climb in Pre-Market Trading Amid Tech Gains and Upcoming Inflation Data	NYSE:ABBV	AbbVie Inc
26/04/2024	06:35	PR Newswire (US)	AbbVie Reports First-Quarter 2024 Financial Results	NYSE:ABBV	AbbVie Inc
25/04/2024	07:00	PR Newswire (US)	New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study	NYSE:ABBV	AbbVie Inc
23/04/2024	07:00	PR Newswire (US)	Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands	NYSE:ABBV	AbbVie Inc
18/04/2024	07:31	PR Newswire (US)	Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis	NYSE:ABBV	AbbVie Inc
12/04/2024	06:30	PR Newswire (US)	AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine	NYSE:ABBV	AbbVie Inc
09/04/2024	07:00	PR Newswire (US)	SkinMedica® Empowers Clear Skin Confidence with a New, Modern Approach to Acne	NYSE:ABBV	AbbVie Inc
04/04/2024	07:00	PR Newswire (US)	AbbVie to Host First-Quarter 2024 Earnings Conference Call	NYSE:ABBV	AbbVie Inc
03/04/2024	07:30	PR Newswire (US)	Allergan Aesthetics Announces the Return of CoolMonth with CoolSculpting®	NYSE:ABBV	AbbVie Inc
01/04/2024	06:50	GlobeNewswire Inc.	NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year	NYSE:ABBV	AbbVie Inc
26/03/2024	06:20	IH Market News	Super Micro Computer and Seagate Shares Surge on Analyst Optimism in Pre-Market Trading, and Latest News	NYSE:ABBV	AbbVie Inc
25/03/2024	10:00	PR Newswire (US)	Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aesthetics	NYSE:ABBV	AbbVie Inc
25/03/2024	07:31	PR Newswire (US)	AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases	NYSE:ABBV	AbbVie Inc
22/03/2024	14:02	PR Newswire (US)	U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients	NYSE:ABBV	AbbVie Inc
21/03/2024	07:00	PR Newswire (US)	ALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY, DRIVE INNOVATION AND LEAD WITH INTEGRITY AS IT HOSTS EXPERT LED SYMPOSIA AT AMWC 2024	NYSE:ABBV	AbbVie Inc
07/03/2024	07:00	PR Newswire (US)	AbbVie to Present at the Barclays 26th Annual Global Healthcare Conference	NYSE:ABBV	AbbVie Inc
06/03/2024	07:03	PR Newswire (US)	AbbVie and Allergan Aesthetics to Present New Data at 2024 Annual AAD Meeting Showcasing Depth and Strength Across Dermatology and Aesthetics Portfolios	NYSE:ABBV	AbbVie Inc
05/03/2024	11:09	PR Newswire (Canada)	Dragonfly a reçu un paiement d'étape à la suite de la prise de dose du premier patient à l'essai clinique de phase 1 d'AbbVie évaluant le DF4101/ABBV-303	NYSE:ABBV	AbbVie Inc
05/03/2024	07:00	PR Newswire (US)	JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval	NYSE:ABBV	AbbVie Inc
05/03/2024	06:00	PR Newswire (US)	Dragonfly has Received Milestone Payment Following Dosing of First Patient in AbbVie Phase 1 Clinical Trial Evaluating DF4101/ABBV-303	NYSE:ABBV	AbbVie Inc
01/03/2024	18:53	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:ABBV	AbbVie Inc
27/02/2024	23:05	PR Newswire (US)	AbbVie and OSE Immunotherapeutics Announce Partnership to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation	NYSE:ABBV	AbbVie Inc
27/02/2024	07:00	GlobeNewswire Inc.	Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea	NYSE:ABBV	AbbVie Inc
27/02/2024	07:00	PR Newswire (US)	AbbVie to Present at the TD Cowen 44th Annual Health Care Conference	NYSE:ABBV	AbbVie Inc
27/02/2024	06:45	PR Newswire (US)	U.S. Food and Drug Administration (FDA) Grants Priority Review of Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma (FL)	NYSE:ABBV	AbbVie Inc

Showing the most relevant articles for your search:NYSE:ABBV

1 2 3 4 5 6 7 8 9 10 Próxima >

Bank of America

American Express

Euro vs US Dollar

JP Morgan Chase

BNP Paribas (QX)

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones